MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2022 International Congress

    Corticobasal syndrome and Parkinson’s disease at the beginning: usefulness of different asymmetrical patterns for early diagnosis.

    G. Donzuso, G. Sciacca, A. Luca, C. Cicero, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: To evaluate R2 Blink Reflex Recovery Cycle (R2BRRC) and cortical thickness in drug-naïve PD patients and in CBS patients for characterizing pathophysiological mechanisms underlying…
  • 2022 International Congress

    Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients

    G. Rizzo, P. Avoni, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: We aimed to assess the efficacy of cannabinoids in painful dystonia of corticobasal syndrome (CBS) patients Background: The clinical phenotype of CBS includes limb…
  • 2022 International Congress

    Absence of nigrosome as a finding in a patient with suspected atypical parkinsonism.

    L. Caballero Sánchez, D. Cerdán Santacruz, C. Gómez López, J. Berrío Suaza, P. Gil Armada, M. álvarez Eulate, A. Castrillo Sanz, A. Mendoza Rodriguez, M. Rodríguez Sanz, C. Tabernero García (Segovia, Spain)

    Objective: Reviewing typical neuroimaging features of the substantia nigra.Noting that the absence of nigrosome 1 has also been seen in atypical parkinsonisms. Background: It is…
  • 2022 International Congress

    Clinicopathologic features of corticobasal syndrome associated with corticobasal degeneration, progressive supranuclear palsy, Alzheimer’s disease, and FTLD-TDP

    S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

    Objective: To compare the clinicopathologic features of corticobasal syndrome (CBS) associated with corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), Alzheimer's disease (AD), and frontotemporal lobar…
  • 2022 International Congress

    Imaging Tau in Atypical Parkinsonisms: Meta-Analysis of in vivo PET Imaging Findings

    A. Mena, A. Strafella (Toronto, Canada)

    Objective: To determine the most accurate and reliable tau PET tracers for providing differential diagnosis of PSP and CBD from PD. Background: Parkinsonism is classified…
  • 2022 International Congress

    Probable Four-repeat tauopathy criteria in Corticobasal Syndrome: diagnostic accuracy, clinical features and imaging biomarkers

    J. Parmera, C. Carneiro, M. Oliveira, P. Barbosa, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki, A. Coutinho (São Paulo, Brazil)

    Objective: To compare the “probable four-repeat (4R)-tauopathy” criteria[1] with the clinical research(cr) criteria for corticobasal degeneration (CBD) [2] regarding diagnostic accuracy to predict a negative…
  • MDS Virtual Congress 2021

    An evaluation of the application of clinical research criteria for corticobasal degeneration in a large clinico-pathological series

    D. Lux, L. Wu, H. Ling, T. Warner, A. Lees, T. Revesz, Z. Jaunmuktane, J. Rohrer, H. Morris (London, United Kingdom)

    Objective: To evaluate diagnostic criteria for corticobasal degeneration (CBD) in relation to pathology and disease course. Background: The overlapping features of CBD and related conditions…
  • MDS Virtual Congress 2021

    Language impairment in Corticobasal Syndrome: from clinical phenotype to biomarkers

    J. Parmera, M. Oliveira, A. Coutinho, I. de Almeida, C. Carneiro, A. Neto, R. Nitrini, C. Buchpiguel, E. Barbosa, S. Brucki (São Paulo, Brazil)

    Objective: To investigate the language impairment profile of patients diagnosed as probable Corticobasal Syndrome (CBS) [1] in light of a multimodal imaging biomarkers analysis, namely…
  • MDS Virtual Congress 2021

    Automated Midbrain-Pons Ratio using Artificial Intelligence Differentiates PSP from other Atypical Parkinsonian Disorders

    M. Peres, G. Leroy, A. Gerhard, M. Hu, J. Klein, P. Leigh, A. Church, D. Burn, H. Morris, J. Rowe, T. Rittman (Cambridge, United Kingdom)

    Objective: Our primary goal was to implement an automated measure of the midbrain to pons ratio (MPR) using an artificial intelligence method. Our second objective…
  • MDS Virtual Congress 2020

    Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome

    I. Aiba, M. Yoshida, T. Shimohata, Y. Hayashi, T. Sano, Y. Saito, S. Murayama, K. Hasegawa, Y. Iwasaki, M. Sakai, K. Wakabayashi, T. Komori, K. Nakashima (Nagoya, Japan)

    Objective: To compare clinical features and natural course of corticobasal degeneration (CBD) presenting as corticobasal syndrome (CBD-CBS) and progressive supranuclear palsy presenting as corticobasal syndrome…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley